Bath & Body Works’ (BBWI) Hold Rating Reiterated at Argus

Argus reaffirmed their hold rating on shares of Bath & Body Works (NYSE:BBWI) in a report published on Friday,Benzinga reports.

Several other research firms have also issued reports on BBWI. Barclays boosted their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research report on Tuesday, November 26th. Telsey Advisory Group reissued an “outperform” rating and issued a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Piper Sandler boosted their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $42.00 to $48.00 in a research report on Friday. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $43.06.

Bath & Body Works Stock Down 1.4 %

BBWI opened at $36.45 on Friday. The stock has a market cap of $7.89 billion, a price-to-earnings ratio of 8.89, a PEG ratio of 1.43 and a beta of 1.82. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99. The company’s 50-day moving average price is $35.75 and its two-hundred day moving average price is $33.68.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.48 earnings per share. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.26 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.19%. Bath & Body Works’s dividend payout ratio is presently 19.51%.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors have recently made changes to their positions in BBWI. True Wealth Design LLC raised its holdings in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in Bath & Body Works in the 3rd quarter worth $39,000. TD Private Client Wealth LLC raised its holdings in Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. Finally, Meeder Asset Management Inc. raised its holdings in Bath & Body Works by 480.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,436 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.